z-logo
open-access-imgOpen Access
SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis
Author(s) -
Yan Zhu,
Lijuan Yang,
Jianqing Wang,
Yan Li,
Youguo Chen
Publication year - 2022
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2022.33.e75
Subject(s) - cisplatin , gene knockdown , ovarian cancer , cancer research , gene silencing , mapk/erk pathway , apoptosis , biology , medicine , microbiology and biotechnology , cancer , kinase , chemotherapy , gene , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom